This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Sanford Burnham Prebys Medical Discovery Institute, Sanford-Burnham Medical Research Institute. Active years: 2018-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2018-2019
Title: Raveendra Panickar Dhanya: Innovator in Metabotropic Glutamate Receptor Modulation
Introduction
Raveendra Panickar Dhanya is a notable inventor based in La Jolla, CA (US). He has made significant contributions to the field of pharmacology, particularly in the development of metabotropic glutamate receptor positive allosteric modulators. With a total of 2 patents, his work has the potential to impact therapeutic approaches for various neurological conditions.
Latest Patents
Dhanya's latest patents focus on metabotropic glutamate receptor positive allosteric modulators (PAMS). These patents detail small molecule active metabotropic glutamate subtype-2 and -3 receptor positive allosteric modulators, along with compositions comprising these compounds. The methods of using these compounds and compositions are also outlined, showcasing their potential applications in medical science.
Career Highlights
Throughout his career, Dhanya has worked with esteemed institutions such as the Sanford Burnham Prebys Medical Discovery Institute and the Sanford Burnham Medical Research Institute. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Dhanya's notable coworkers include Douglas J. Sheffler and Nicholas D. P. Cosford. Their collaborative efforts have further advanced the research and development of innovative therapeutic solutions.
Conclusion
Raveendra Panickar Dhanya's contributions to the field of pharmacology through his patents on metabotropic glutamate receptor modulators highlight his role as an influential inventor. His work continues to pave the way for advancements in neurological therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile